BioSpace News Archive

Press Releases

New JNCCN Study Suggests Medicaid Expansion Improves Cancer Care and Survival for People with Aggressive Type of Breast Cancer

October 25, 2024
·
5 min read
Press Releases

Agomab Announces $89 Million Series D Financing to Support Broad Fibrosis-Focused Pipeline

October 25, 2024
·
2 min read
Press Releases

Zymeworks Presents New Preclinical Data on Antibody-Drug Conjugate Programs at EORTC-NCI-AACR Conference

October 25, 2024
·
10 min read
Business

Y-mAbs Announces Third Quarter 2024 Conference Call and Webcast

October 25, 2024
·
5 min read
Press Releases

BridgeBio Shares Positive Data from High Dose Cohort of Phase 1/2 CANaspire Study of Gene Therapy BBP-812 for Canavan Disease at ESGCT 2024

October 25, 2024
·
8 min read
Press Releases

Prelude Therapeutics Presents New Data from SMARCA Degrader Portfolio at the 36th EORTC-NCI-AACR Symposium

October 25, 2024
·
10 min read
Press Releases

Verrica Pharmaceuticals Announces Acceptance of Two Abstracts Featuring Positive Preliminary Topline Results of VP-315 for the Treatment of Basal Cell Carcinoma at the 2024 Fall Clinical Dermatology Conference

October 25, 2024
·
6 min read
Press Releases

Passage Bio Presents Preclinical and Interim Clinical Data for PBFT02 in FTD-GRN at the European Society of Gene & Cell Therapy (ESGCT) 31st Annual Conference

October 25, 2024
·
7 min read
Press Releases

Kymera Therapeutics Announces Dosing of First Participant in Phase 1 Clinical Trial of KT-621, a First-in-Class Oral STAT6 Degrader, for the Treatment of TH2 Immuno-Inflammatory Diseases

October 25, 2024
·
5 min read
Press Releases

iTeos Therapeutics to Highlight Inupadenant Preclinical, Translational, and Phase 2 A2A-005 Clinical Trial Data in 2L NSCLC at ESMO Immuno-Oncology Congress

October 25, 2024
·
3 min read